MedTrace Logo

LongVentKids Study

NCT04112459 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2019-10-02

No results posted yet for this study

Summary

Scientific advances, population growth, lower mortality, and increasing complexity of diseases have boosted up the number of patients requiring prolonged breathing assistance with mechanical ventilators in the pediatric intensive care units (PICU) in many parts of the developed world. Previous studies also suggest that there is a small group of children who actually need such a high level of support for extended periods of time, utilizing a lot of human and technical resources. We defined children with prolonged mechanical ventilation (PMV) if they required supports with a breathing machine for more than 14 days. We propose an international point prevalence study of children requiring PMV in PICU. We will conduct the study in multiple centers in several different regions, including North and South America, Europe, and Asian countries, with a strong relationship with local physician colleagues. Practice for patients requiring PMV will be examined including the type and size of local PICU, admission and discharge policies, and patient and treatment modalities administered to such patients, types of professionals looking after patients in PMV, types of health care. We anticipate a high variability in practices suggesting a need to further standardize the management of PMV.. Specifically, as an immediate consequence, by comparing and understanding the differences in patient demographics, practice details among PICUs in regards to the background factors of local PICUs and their patients, practitioners will share their way of dealing with such patients. In that way, this study will support the need to generate guidelines and lead to patient care improvement in PICUs.

Conditions

  • Prolonged Mechanical Ventilation in Pediatric Intensive Care Unit

Interventions

OTHER

prolonged mechanical ventilation

No intervention will be applied in this study

Sponsors & Collaborators

  • Réseau en Santé Respiratoire du Québec

    collaborator UNKNOWN

  • Fonds de la Recherche en Santé du Québec

    collaborator OTHER_GOV

  • Women and Children's Health Research Institute, Canada

    collaborator OTHER

  • Réseau mère-enfant de la francophonie

    collaborator UNKNOWN

  • St. Justine's Hospital

    lead OTHER

Principal Investigators

  • Philippe Jouvet, MD PhD MBA · St. Justine's Hospital

Eligibility

Min Age
37 Weeks
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-04
Primary Completion
2021-09-03
Completion
2022-09-04

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04112459 on ClinicalTrials.gov